Inhibition of DNA Topoisomerase Type II α (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study

6Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

In this study, mitoxantrone and its halogenated derivatives have been designed by density functional theory (DFT) to explore their structural and thermodynamical properties. The performance of these drugs was also evaluated to inhibit DNA topoisomerase type IIα (TOP2A) by molecular docking calculation. Noncovalent interactions play significant role in improving the performance of halogenated drugs. The combined quantum and molecular mechanics calculations revealed that CF3 containing drug shows better preference in inhibiting the TOP2A compared to other modified drugs.

Cite

CITATION STYLE

APA

Abu Saleh, M., Solayman, M., Hoque, M. M., Khan, M. A. K., Sarwar, M. G., & Halim, M. A. (2016). Inhibition of DNA Topoisomerase Type II α (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study. BioMed Research International, 2016. https://doi.org/10.1155/2016/6817502

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free